Cochrane Abstracts
Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Bendamustine for Patients With Indolent B Cell Lymphoid Malignancies Including Chronic Lymphocytic Leukaemia." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434406/all/Bendamustine_for_patients_with_indolent_B_cell_lymphoid_malignancies_including_chronic_lymphocytic_leukaemia_New.
Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434406/all/Bendamustine_for_patients_with_indolent_B_cell_lymphoid_malignancies_including_chronic_lymphocytic_leukaemia_New. Accessed April 21, 2025.
Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434406/all/Bendamustine_for_patients_with_indolent_B_cell_lymphoid_malignancies_including_chronic_lymphocytic_leukaemia_New
Bendamustine for Patients With Indolent B Cell Lymphoid Malignancies Including Chronic Lymphocytic Leukaemia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434406/all/Bendamustine_for_patients_with_indolent_B_cell_lymphoid_malignancies_including_chronic_lymphocytic_leukaemia_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia
ID - 434406
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434406/all/Bendamustine_for_patients_with_indolent_B_cell_lymphoid_malignancies_including_chronic_lymphocytic_leukaemia_New
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
